EA200600101A1 - Лечение депрессии и других аффективных расстройств - Google Patents

Лечение депрессии и других аффективных расстройств

Info

Publication number
EA200600101A1
EA200600101A1 EA200600101A EA200600101A EA200600101A1 EA 200600101 A1 EA200600101 A1 EA 200600101A1 EA 200600101 A EA200600101 A EA 200600101A EA 200600101 A EA200600101 A EA 200600101A EA 200600101 A1 EA200600101 A1 EA 200600101A1
Authority
EA
Eurasian Patent Office
Prior art keywords
depression
treatment
affective disorders
gaboxadol
preparation
Prior art date
Application number
EA200600101A
Other languages
English (en)
Inventor
Конни Санчес
Бьярке Эберт
Original Assignee
Х. Лундбекк А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=58707228&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200600101(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Х. Лундбекк А/С filed Critical Х. Лундбекк А/С
Priority claimed from PCT/DK2004/000459 external-priority patent/WO2004112786A2/en
Publication of EA200600101A1 publication Critical patent/EA200600101A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Настоящее изобретение относится к применению габоксадола для приготовления фармацевтической композиции для лечения депрессии. Кроме того, оно относится к применению габоксадола для приготовления фармацевтической композиции, которая предназначена для использования в комбинации с ингибитором обратного захвата серотонина или любым другим соединением, которое вызывает повышение уровня внеклеточного серотонина.
EA200600101A 2003-06-25 2004-06-25 Лечение депрессии и других аффективных расстройств EA200600101A1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200300956 2003-06-25
DKPA200400016 2004-01-07
PCT/DK2004/000459 WO2004112786A2 (en) 2003-06-25 2004-06-25 Gaboxadol for treating depression and other affective disorders

Publications (1)

Publication Number Publication Date
EA200600101A1 true EA200600101A1 (ru) 2006-06-30

Family

ID=58707228

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200600101A EA200600101A1 (ru) 2003-06-25 2004-06-25 Лечение депрессии и других аффективных расстройств

Country Status (10)

Country Link
KR (1) KR20060025192A (ru)
AR (1) AR047550A1 (ru)
CA (2) CA2692334A1 (ru)
CL (2) CL2004001607A1 (ru)
EA (1) EA200600101A1 (ru)
IS (1) IS8138A (ru)
ME (2) ME00030B (ru)
NO (1) NO20060229L (ru)
RS (1) RS20050911A (ru)
TW (1) TW200509918A (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3883566A4 (en) 2018-11-21 2022-09-07 Certego Therapeutics Inc. GABOXADOL FOR SUICIDE RISK REDUCTION AND RAPID DEPRESSION RELIEF
US11597726B2 (en) 2020-05-20 2023-03-07 Certego Therapeutics Inc. Ring deuterated gaboxadol and its use for the treatment of psychiatric disorders

Also Published As

Publication number Publication date
TW200509918A (en) 2005-03-16
AR047550A1 (es) 2006-01-25
ME00030B (me) 2010-06-10
CL2004001607A1 (es) 2005-05-27
IS8138A (is) 2005-11-21
CA2529805A1 (en) 2004-12-29
KR20060025192A (ko) 2006-03-20
RS20050911A (en) 2007-08-03
NO20060229L (no) 2006-01-16
CL2010000166A1 (es) 2010-07-02
CA2692334A1 (en) 2004-12-29
MEP1908A (xx) 2010-02-10

Similar Documents

Publication Publication Date Title
IL172631A0 (en) Gaboxadol for treating depression and other affective disorders
MY153424A (en) Modulators of indoleamine 2,3-dioxygenase and methods of using the same
PA8596901A1 (es) Inhibidores de p38 y metodos de uso de ellos
EA200870019A1 (ru) Лактамовые соединения и способы их применения
EA201370208A1 (ru) Формы рифаксимина и их применение
EA200700489A1 (ru) Новые бензоконденсированные гетероарилсульфамидные производные, полезные в качестве противоконвульсивных средств
EA200601746A1 (ru) Применение ротиготина для лечения и предупреждения синдрома "паркинсонизм-плюс"
NO20060242L (no) Kombinasjonen av en serotonin-reopptaksinhibitor og agomelatin
DK1948606T3 (da) 3, 5-disubstituerede phenyl-piperidiner som modulatorer af dopaminneurotransmission
EA201500403A1 (ru) Соединения, активирующие теломеразу, и способы их применения
EA200802072A1 (ru) Ликопин для лечения нарушения обмена веществ
SE0401465D0 (sv) New substituted piperdines as modulators of dopamine neurotransmission
CL2008003231A1 (es) Compuestos derivados de 1,3-dihidro-5-isobenzofurancarbonitrilo sustituido, inhibidores selectivos de la recaptacion de serotonina; composicion farmaceutica; procedimiento de preparacion; utiles en el tratamiento y/o prevencion de la eyaculacion prematura.
AR047715A1 (es) Combinaciones de analepticos y antdepresivos
EA200501802A1 (ru) Сочетание аналептина модафинила и антидепрессанта для лечения депресии
EA200600101A1 (ru) Лечение депрессии и других аффективных расстройств
EA200600998A1 (ru) Фармацевтическая композиция, содержащая цинк-гиалуронановый комплекс, предназначенная для лечения рассеянного склероза
ATE536874T1 (de) Dreifache monoamin-wiederaufnahmehemmer zur behandlung von chronischen schmerzen
EA200600531A1 (ru) Сочетание ингибитора обратного захвата серотонина и локсапина
UA90656C2 (ru) Габоксадол для лечения депрессии
EA200600183A1 (ru) Сочетание ингибитора обратного захвата серотонина и агомелатина
EA200600534A1 (ru) Сочетание ингибитора обратного захвата серотонина и амоксапина
NO20061427L (no) Kombinasjonen av en serotonin-reoppttaksinhibitor og amoxapin